Analysts Expect Arotech Co. (ARTX) to Post $0.03 Earnings Per Share

Arotech Co. (NASDAQ:ARTX) has been assigned an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy recommendation.

Brokerages have set a 1 year consensus price target of $4.50 for the company and are predicting that the company will post $0.03 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Arotech an industry rank of 106 out of 256 based on the ratings given to related companies.

A number of research firms recently weighed in on ARTX. Zacks Investment Research upgraded Arotech from a “sell” rating to a “hold” rating in a research note on Wednesday, September 19th. ValuEngine lowered shares of Arotech from a “hold” rating to a “sell” rating in a research report on Wednesday, September 12th.

ARTX stock opened at $2.66 on Wednesday. The company has a quick ratio of 1.68, a current ratio of 2.07 and a debt-to-equity ratio of 0.09. The stock has a market capitalization of $70.45 million, a P/E ratio of 16.63 and a beta of 1.50. Arotech has a 1-year low of $2.37 and a 1-year high of $4.15.

Arotech (NASDAQ:ARTX) last released its quarterly earnings data on Tuesday, November 6th. The aerospace company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.03. The firm had revenue of $23.84 million during the quarter, compared to the consensus estimate of $23.50 million. Arotech had a return on equity of 7.38% and a net margin of 5.72%. During the same period in the previous year, the company posted $0.06 earnings per share. On average, sell-side analysts anticipate that Arotech will post 0.15 EPS for the current fiscal year.

In other Arotech news, Chairman Jon B. Kutler purchased 20,000 shares of the stock in a transaction dated Monday, November 19th. The stock was acquired at an average cost of $2.62 per share, for a total transaction of $52,400.00. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Kenneth W. Cappell purchased 10,000 shares of the stock in a transaction dated Monday, November 12th. The shares were acquired at an average price of $2.80 per share, with a total value of $28,000.00. The disclosure for this purchase can be found here. In the last three months, insiders bought 71,000 shares of company stock worth $191,360. Insiders own 9.40% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ARTX. Marshall Wace LLP bought a new position in Arotech in the 3rd quarter worth approximately $55,000. Alambic Investment Management L.P. purchased a new stake in shares of Arotech during the 2nd quarter valued at about $126,000. B. Riley Financial Inc. boosted its holdings in shares of Arotech by 44.4% during the 3rd quarter. B. Riley Financial Inc. now owns 154,067 shares of the aerospace company’s stock valued at $524,000 after acquiring an additional 47,350 shares during the last quarter. Ancora Advisors LLC boosted its holdings in shares of Arotech by 25.2% during the 3rd quarter. Ancora Advisors LLC now owns 323,035 shares of the aerospace company’s stock valued at $1,098,000 after acquiring an additional 65,101 shares during the last quarter. Finally, First Wilshire Securities Management Inc. purchased a new stake in shares of Arotech during the 3rd quarter valued at about $279,000. Institutional investors and hedge funds own 28.56% of the company’s stock.

About Arotech

Arotech Corporation provides defense and security products worldwide. The company's Training and Simulation division develops, manufactures, and markets multimedia and interactive digital solutions for engineering, use-of-force training, and operator training of military, law enforcement, security, emergency services, and other personnel.

Further Reading: Stop Order Uses For Individual Investors

Get a free copy of the Zacks research report on Arotech (ARTX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Arotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arotech and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit